T103	ZeroArticleNP 0 10	Drug Label
T104	ZeroArticleNP 15 33	drug brand Cardura
T105	DefiniteNP 218 239	the inert ingredients
T106	IndefiniteNP 132 151	a known sensitivity
T107	DefiniteNP 387 407	the upright position
T108	IndefiniteNP 303 341	other alpha-adrenergic blocking agents
T109	IndefiniteNP 426 449	other postural symptoms
T110	DefiniteNP 517 531	the first dose
T111	IndefiniteNP 565 582	a dosage increase
T112	ZeroArticleNP 590 597	therapy
T113	PersonalPronoun 704 706	it
T114	DefiniteNP 651 665	the likelihood
T115	DefiniteNP 753 766	the 1 mg dose
T116	DefiniteNP 768 773	The 2
T117	ZeroArticleNP 782 794	8 mg tablets
T118	ZeroArticleNP 807 822	initial therapy
T119	DefiniteNP 953 973	the recommended dose
T120	ZeroArticleNP 975 1009	Additional antihypertensive agents
T121	DefiniteNP 1179 1186	the day
T122	DefiniteNP 1235 1245	the safety
T123	IndefiniteNP 1201 1231	an early investigational study
T124	DefiniteNP 1572 1596	the subjects experienced
T125	DefiniteNP 1660 1674	the first dose
T126	DefiniteNP 1705 1714	the study
T127	IndefiniteNP 1452 1465	another study
T128	DefiniteNP 1736 1761	the normotensive subjects
T129	DemonstrativeNP 1719 1729	this study
T130	IndefiniteNP 1882 1896	a 4% incidence
T131	DefiniteNP 2170 2187	the starting dose
T132	DemonstrativeNP 2145 2157	these events
T133	DefiniteNP 2354 2366	the patients
T134	DefiniteNP 2465 2510	the open-label, long-term extension follow-up
T135	IndefiniteNP 2703 2732	a clinical pharmacology study
T136	DefiniteNP 2801 2812	the patient
T137	IndefiniteNP 2833 2853	a recumbent position
T138	ZeroArticleNP 2984 3002	alpha1 antagonists
T139	DefiniteNP 3272 3287	the seriousness
T140	DefiniteNP 3291 3304	the condition
T141	DemonstrativeNP 3169 3183	this condition
T142	DefiniteNP 3406 3418	the prostate
T143	DefiniteNP 3434 3446	the symptoms
T144	DefiniteNP 3471 3488	the two disorders
T145	DefiniteNP 3523 3535	the prostate
T146	ZeroArticleNP 3586 3593	therapy
T147	IndefiniteNP 3715 3728	some patients
T148	ZeroArticleNP 3759 3774	alpha1 blockers
T149	DefiniteNP 3833 3848	the combination
T150	DefiniteNP 4052 4060	the iris
T151	DefiniteNP 4068 4101	the phacoemulsification incisions
T152	IndefiniteNP 3852 3866	a flaccid iris
T153	DemonstrativeNP 3776 3788	This variant
T154	ZeroArticleNP 4000 4024	standard mydriatic drugs
T155	PossessivePronoun 4174 4198	their surgical technique
T156	DefiniteNP 4103 4114	The patient
T157	DefiniteNP 4208 4223	the utilization
T158	ZeroArticleNP 4262 4285	viscoelastic substances
T159	IndefiniteNP 4315 4324	a benefit
T160	ZeroArticleNP 4337 4359	alpha1 blocker therapy
T161	DefiniteNP 4430 4464	the most severe orthostatic effect
T162	DefiniteNP 4619 4627	the time
T163	IndefiniteNP 4477 4491	other symptoms
T164	ZeroArticleNP 4605 4612	therapy
T165	IndefiniteNP 4754 4766	all patients
T166	DemonstrativeNP 4665 4679	These symptoms
T167	ZeroArticleNP 4806 4813	therapy
T168	ZeroArticleNP 4931 4938	therapy
T169	DefiniteNP 5139 5156	the placebo group
T170	IndefiniteNP 5021 5043	an increased frequency
T171	DefiniteNP 5229 5242	the incidence
T172	DefiniteNP 5353 5366	The incidence
T173	DefiniteNP 5475 5497	The titration interval
T174	DemonstrativeNP 5501 5514	these studies
T175	PersonalPronoun 5709 5711	it
T176	IndefiniteNP 5855 5863	a supine
T177	ZeroArticleNP 5659 5677	alpha1 antagonists
T178	DefiniteNP 5908 5919	the patient
T179	DefiniteNP 5940 5959	the supine position
T180	DemonstrativeNP 5968 5980	this measure
T181	ZeroArticleNP 6040 6059	vasopressor therapy
T182	IndefiniteNP 6073 6105	A transient hypotensive response
T183	IndefiniteNP 6113 6131	a contraindication
T184	DefiniteNP 6250 6265	the possibility
T185	DefiniteNP 6318 6332	the initiation
T186	DefiniteNP 6410 6424	the first dose
T187	IndefiniteNP 6432 6449	a dosage increase
T188	ZeroArticleNP 6336 6343	therapy
T189	ZeroArticleNP 6477 6484	therapy
T190	PersonalPronoun 6512 6516	They
T191	ZeroArticleNP 6625 6642	doxazosin therapy
T192	PersonalPronoun 6644 6648	They
T193	DefiniteNP 6675 6683	the need
T194	IndefiniteNP 6837 6864	a sitting or lying position
T195	DemonstrativeNP 6759 6773	these symptoms
T196	PersonalPronoun 6929 6933	they
T197	DefiniteNP 6956 6969	the physician
T198	IndefiniteNP 7099 7143	any selective alpha1 adrenoceptor antagonist
T199	DefiniteNP 7249 7264	the possibility
T200	IndefiniteNP 7280 7288	a result
T201	ZeroArticleNP 7307 7325	alpha1 antagonists
T202	DemonstrativeNP 7353 7371	this adverse event
T203	PersonalPronoun 7389 7393	they
T204	PersonalPronoun 7415 7417	it
T205	PersonalPronoun 7498 7500	it
T206	DefiniteNP 7617 7641	the plasma concentration
T207	IndefiniteNP 7726 7745	an alpha1 inhibitor
T208	IndefiniteNP 7764 7793	a 5-alpha reductase inhibitor
T209	DefiniteNP 7906 7925	the concomitant use
T210	DemonstrativeNP 7983 7992	this time
T211	ZeroArticleNP 7929 7946	alpha1 inhibitors
T212	ZeroArticleNP 7951 7979	5-alpha reductase inhibitors
T213	ZeroArticleNP 8145 8150	drugs
T214	DefiniteNP 8390 8402	the mean WBC
T215	IndefiniteNP 8514 8526	a phenomenon
T216	IndefiniteNP 8537 8563	other alpha-blocking drugs
T217	DefiniteNP 8582 8595	the incidence
T218	DefiniteNP 8752 8776	the two treatment groups
T219	IndefiniteNP 8778 8786	A search
T220	IndefiniteNP 8795 8806	a data base
T221	DefiniteNP 9061 9073	the last day
T222	IndefiniteNP 9039 9057	a single low value
T223	DefiniteNP 9155 9173	the 1000/mm3 range
T224	DefiniteNP 9282 9289	the end
T225	DefiniteNP 9293 9302	the study
T226	IndefiniteNP 9227 9237	a decrease
T227	IndefiniteNP 9243 9254	a WBC count
T228	DefiniteNP 9390 9398	the WBCs
T229	DefiniteNP 9520 9531	the low WBC
T230	IndefiniteNP 9508 9516	a result
T231	DefiniteNP 9785 9795	the effect
T232	IndefiniteNP 9799 9838	other highly plasma protein-bound drugs
T233	IndefiniteNP 9899 9911	any evidence
T234	IndefiniteNP 9915 9942	an adverse drug interaction
T235	ZeroArticleNP 9965 9983	thiazide diuretics
T236	ZeroArticleNP 9985 10005	beta-blocking agents
T237	ZeroArticleNP 10011 10047	nonsteroidal anti-inflammatory drugs
T238	DefiniteNP 10101 10119	the administration
T239	IndefiniteNP 10052 10078	a placebo-controlled trial
T240	IndefiniteNP 10123 10141	a single 1 mg dose
T241	IndefiniteNP 10167 10185	a four-day regimen
T242	IndefiniteNP 10238 10252	a 10% increase
T243	IndefiniteNP 10293 10344	a slight but not statistically significant increase
T244	DefiniteNP 10391 10416	The clinical significance
T245	DemonstrativeNP 10420 10433	this increase
T246	IndefiniteNP 10537 10546	a variety
T247	ZeroArticleNP 10483 10498	CARDURA tablets
T248	ZeroArticleNP 10550 10573	concomitant medications
T249	DefiniteNP 10699 10718	the following drugs
T250	ZeroArticleNP 10671 10678	tablets
T251	ZeroArticleNP 10722 10734	drug classes
T252	ZeroArticleNP 10818 10830	combinations
T253	ZeroArticleNP 10990 11011	cardiovascular agents
T254	ZeroArticleNP 11087 11130	gastrointestinal agents (e.g., antacids), 7
T255	ZeroArticleNP 11132 11168	hypoglycemics and endocrine drugs, 8
T256	ZeroArticleNP 11170 11217	sedatives and tranquilizers (e.g., diazepam), 9
T257	ZeroArticleNP 11219 11240	cold and flu remedies
T258	IndefiniteNP 11285 11324	a phosphodiesterase-5 (PDE-5) inhibitor
T259	DefiniteNP 11810 11832	the human AUC exposure
T260	IndefiniteNP 11471 11493	An increased incidence
T261	IndefiniteNP 11838 11849	a 12 mg/day
T262	DefiniteNP 11935 11950	the same manner
T263	DefiniteNP 12181 12190	the study
T264	DistributiveNP 12195 12209	either species
T265	DefiniteNP 12369 12386	the Cmax exposure
T266	IndefiniteNP 12407 12418	a 12 mg/day
T267	IndefiniteNP 12531 12542	a 12 mg/day
T268	DemonstrativeNP 12211 12224	These lesions
T269	DefiniteNP 12874 12891	The highest doses
T270	DefiniteNP 12905 12930	the rat and mouse studies
T271	DefiniteNP 13033 13046	the human AUC
T272	IndefiniteNP 12957 12966	a measure
T273	IndefiniteNP 13050 13056	a dose
T274	IndefiniteNP 13356 13367	a 12 mg/day
T275	DemonstrativeNP 13380 13391	This effect
T276	ZeroArticleNP 13427 13442	drug withdrawal
T277	IndefiniteNP 13474 13485	any effects
T278	DefiniteNP 13825 13834	the fetus
T279	IndefiniteNP 13757 13768	a 12 mg/day
T280	ZeroArticleNP 13681 13707	plasma drug concentrations
T281	DefiniteNP 13872 13882	the rabbit
T282	IndefiniteNP 13836 13852	A dosage regimen
T283	DefiniteNP 14174 14186	the placenta
T284	IndefiniteNP 14425 14436	a 12 mg/day
T285	DefiniteNP 14786 14819	the maternal plasma concentration
T286	IndefiniteNP 14625 14643	a single oral dose
T287	IndefiniteNP 14734 14757	a maximum concentration
T288	PersonalPronoun 14821 14823	It
T289	DemonstrativeNP 14845 14854	this drug
T290	IndefiniteNP 14989 15005	a nursing mother
T291	ZeroArticleNP 14890 14900	many drugs
T292	DefiniteNP 15023 15033	The safety
T293	IndefiniteNP 15066 15091	an antihypertensive agent
T294	DefiniteNP 15147 15183	The safety and effectiveness profile
T295	PersonalPronoun 15412 15416	they
T296	DefiniteNP 15547 15558	the elderly
T297	DefiniteNP 15671 15682	the low end
T298	DefiniteNP 15686 15702	the dosing range
T299	DefiniteNP 15715 15736	the greater frequency
T300	IndefiniteNP 15612 15630	an elderly patient
T301	IndefiniteNP 15816 15834	other drug therapy
T1	Drug_Class 309 341	alpha-adrenergic blocking agents
T2	Drug 287 296	Doxazosin
T3	Drug_Class 986 1009	antihypertensive agents
T5	Drug_Class 2984 3002	alpha1 antagonists
T6	Drug 3014 3023	doxazosin
T8	Drug_Class 7729 7745	alpha1 inhibitor
T7	Drug 7715 7724	doxazosin
T10	Drug_Class 7766 7793	5-alpha reductase inhibitor
T9	Drug 7751 7762	finasteride
T11	Drug 10189 10204	oral cimetidine
T13	Drug 10268 10277	doxazosin
T17	Drug 10380 10389	doxazosin
T19	Drug 10437 10446	doxazosin
T20	Drug 11272 11279	CARDURA
T21	Drug_Class 11287 11324	phosphodiesterase-5 (PDE-5) inhibitor
T22	Drug_Class 10011 10047	nonsteroidal anti-inflammatory drugs
T23	Drug_Class 9965 9983	thiazide diuretics
T24	Drug_Class 9985 10005	beta-blocking agents
T25	Drug_Class 5659 5677	alpha1 antagonists
T26	Drug_Class 7307 7325	alpha1 antagonists
T27	Drug_Class 15069 15091	antihypertensive agent
T28	Drug 9711 9718	digoxin
T29	Drug 11029 11048	hydrochlorothiazide
T30	Drug 11050 11061	propranolol
T31	Drug_Class 11067 11082	corticosteroids
T32	Drug 9730 9739	phenytoin
T33	Drug 10880 10892	erythromycin
T34	Drug 9744 9756	indomethacin
T35	Drug 10843 10855	indomethacin
T36	Drug 10789 10796	aspirin
T37	Drug 9720 9728	warfarin
T38	Drug 46 55	doxazosin
T39	Drug 197 206	doxazosin
T40	Drug 1069 1078	doxazosin
T41	Drug 1289 1298	doxazosin
T42	Drug 1546 1555	doxazosin
T43	Drug 1839 1848	doxazosin
T44	Drug 2319 2328	doxazosin
T45	Drug 2384 2393	doxazosin
T46	Drug 2429 2438	doxazosin
T47	Drug 5275 5284	doxazosin
T48	Drug 5444 5453	doxazosin
T49	Drug 6625 6634	doxazosin
T50	Drug 9595 9604	doxazosin
T51	Drug 9842 9851	doxazosin
T52	Drug 10145 10154	doxazosin
T53	Drug 11653 11662	doxazosin
T54	Drug 11763 11772	doxazosin
T55	Drug 11962 11971	doxazosin
T56	Drug 12728 12737	doxazosin
T57	Drug 13251 13260	doxazosin
T58	Drug 13489 13498	doxazosin
T59	Drug 14229 14238	doxazosin
T60	Drug 14382 14391	doxazosin
T61	Drug 14688 14697	doxazosin
T62	Drug 175 183	prazosin
T63	Drug 10894 10906	trimethoprim
T64	Drug 11019 11027	atenolol
T67	Drug 185 194	terazosin
T68	Drug_Class 10946 10960	antihistamines
T69	Drug_Class 11118 11126	antacids
T70	Drug 26 33	Cardura
T71	Drug 88 95	CARDURA
T72	Drug 3599 3606	CARDURA
T73	Drug 4468 4475	CARDURA
T74	Drug 6152 6159	CARDURA
T75	Drug 7088 7095	CARDURA
T76	Drug 7593 7600	CARDURA
T77	Drug 8020 8027	CARDURA
T78	Drug 8327 8334	CARDURA
T79	Drug 8662 8669	CARDURA
T80	Drug 9465 9472	CARDURA
T81	Drug 9667 9674	CARDURA
T82	Drug 9861 9868	CARDURA
T83	Drug 10483 10490	CARDURA
T84	Drug 10663 10670	CARDURA
T85	Drug 14077 14084	CARDURA
T86	Drug 14666 14673	CARDURA
T87	Drug 14962 14969	CARDURA
T88	Drug 15055 15062	CARDURA
T89	Drug 15187 15194	CARDURA
T90	Drug 15319 15326	CARDURA
T91	Drug 10798 10805	codeine
T92	Drug 10810 10817	codeine
T93	Drug_Class 10562 10573	medications
T15	Drug_Class 10739 10766	analgesic/anti-inflammatory
T16	Drug_Class 10861 10872	antibiotics
T18	Drug_Class 10990 11011	cardiovascular agents
T94	Drug_Class 11087 11110	gastrointestinal agents
T95	Drug_Class 11132 11165	hypoglycemics and endocrine drugs
T96	Drug_Class 11170 11197	sedatives and tranquilizers
T97	Drug_Class 11219 11240	cold and flu remedies
T302	SPAN 4148 4170	possible modifications
T303	SPAN 6217 6225	Patients
T304	SPAN 6900 6912	palpitations
T305	SPAN 7327 7335	Patients
T306	SPAN 7405 7413	priapism
T307	SPAN 7439 7466	immediate medical attention
T308	SPAN 15343 15361	sufficient numbers
R12	Appositive Attribute:T208 Head:T7
R13	Anaphora Anaphor:T289 Antecedent:T61
R14	Cataphora Cataphor:T249 Consequent:T36
R15	Cataphora Cataphor:T249 Consequent:T92
R16	Cataphora Cataphor:T249 Consequent:T91
